PharmTech Europe, Weekly Alert
Having trouble viewing this e-mail? CLICK HERE

PharmTech Europe
17 September 2019

PHARMTECH.COM

CURRENT ISSUE

SUBSCRIBE

FORWARD

twitter twitter
advertisement

TOP STORIES

Industry and Health Trade Union Respond to Government Review into Prescription Meds

The ABPI and BMA have issued responses to the publication of a government report into the scale and distribution of prescribed medicines in England.
/ read more /


Roche, Spark Therapeutics Acquisition Delayed Under Regulatory Review

Roche has extended its offering period for the purchase of Spark to provide US and UK regulatory authorities with additional time to complete their review of the acquisition.
/ read more /


advertisement


Subscribe

Subscribers can enjoy each full issue of Pharm Tech Europe in print, or via Pharm Tech Europe apps.

subscription offers
subscribe

Industry News

New Initiative Set to Boost UK SMEs Engagement with China’s Healthcare Market

BIA has signed a memorandum of understanding with AstraZeneca and the Wuxi International Life-science Innovation Campus (I-Campus) to boost access for UK SMEs in China.
/ read more /


Collaboration Aims to Drive Commercialization of Next-Generation Therapies

TrakCel and McKesson have formed a collaboration that is aimed at accelerating commercialization of cell and gene therapies by leveraging services to enable a more efficient development pathway.
/ read more /


More Industry News

advertisement


Regulatory News

EMA Initiates Review into Picato

EMA has started a data review of Picato (ingenol mebutate) to investigate the potential for skin cancer risk.
/ read more /


Roche Gains Further Approval by EC for Tecentriq Indications

EC has granted marketing authorization approval to Roche for Tecentriq (atezolizumab), in combination with chemotherapy, as a first-line treatment for patients with extensive-stage small cell lung cancer.
/ read more /


More Regulatory News

advertisement


Bio/Pharma News

Bayer Licenses GlymaxX Antibody Technology from ProBioGen

Bayer will use ProBioGen’s GlymaxX technology to maximize the potency of its antibody drug candidate in development for oncological indications.
/ read more /


Mallinckrodt Pharmaceuticals Sells CDMO Subsidiary for $250 Million

The transaction is set to be completed in the fourth quarter of 2019.
/ read more /


More Bio/Pharma News

Supplier News

BioCity Invests in Novel 'Self Care' Approach

BioCity has invested in Maxwellia, a company based at Alderley Park in the United Kingdom that is driving industry movement towards self-care therapeutics.
/ read more /


ACG Announces Competition Winners

ACG Group has announced the winners of its 'Art in a Capsule' competition, where entrants were challenged to create miniature works of art that could fit inside a capsule.
/ read more /


More Supplier News

FEATURED TOPICS

SCALE UP

Scale-Up: Getting It Right the First Time

Front-end focus and new approaches are speeding scale-up and reducing costs, while scale-down and scale-out become increasingly important.
/ read more /

 

VIEWPOINTS

Pharma's Got Talent?

Government statistics show that pharma can be an illustrious career for graduates, which must be taken advantage of by industry to avoid skills shortages.
/ read more /

ANALYTICS

Container Closure Integrity Testing of Finished Sterile Injectable Product

As regulatory guidance has evolved changes in CCIT testing have also become apparent. In this article, possible CCIT strategy approaches are outlined.
/ read more /

MANUFACTURING

The Road to Real-Time Release: At-line NIR Testing

At-line NIR measurements can replace a laboratory HPLC measurement for API content in oral solid-dosage drug manufacturing.
/ read more /


Product Profiles


Shimadzu

i-Series Plus integrated HPLC
Significantly improved analytical productivity with automated pretreatment operations
Shimadzu's i-Series Plus expands the product line and improves performance and user-friendliness. With i-Series Plus, pretreatment operations have been automated, such as the processes to dilute samples and add reagents.
/ Read more/


Veltek Associates, Inc.

Cart2Core™- Aseptic Cart Transferring System
VAI's Cart2Core®, a patent pending technology, virtually eliminates the problematic issue of correct aseptic cart transference by making the cart top transferable to a new base at each new classification.
/ Read more/


UPCOMING WEBCAST

How Can You Transform the Patient Experience through Digital Transformation?
Wednesday, September 25, 2019 at 9am EDT | 2pm BST | 3pm CEST
Register Now


ON DEMAND WEBCAST

Implantable Systems and Microparticle Depots: Meeting the Formulation and Manufacturing Challenges of Long-Acting Drug Delivery"
On Demand
Learn more


Events

Particles in Injectables Conference

Berlin, Germany

24–25 September 2019

#PharmaGlass – free workshop: introduction to the use, analysis and verification of glass primary packaging

Sheffield, UK

9 October 2019

Wearable Injectors and Connected Devices Conference 2019

London, UK

9–10 October 2019

more events

eBOOKS

Biologics and Sterile Drug Manufacturing 2019

The editors explore novel technologies for the formulation, manufacture, purification, and delivery of sterile small- and large-molecule drugs including single-use systems, facilities and equipment, contamination issues, and process analytics.

contribute | CONTACT EDITORS | CONTACT SALES | subscribe | advertise